Do patients with advanced germ cell tumors still need Postchemotherapy Retroperitoneal Lymph Node Dissection (PC-RPLND) if the two best models predict a “benign” pathohistology?

Bibliographic Details
Main Authors:	T. Nestler, P. Paffenholz, B. Baeßler, M. Hellmich, A. Hiester, A. Nini, D. Pfister, P. Albers, A. Heidenreich
Format:	Article
Language:	English
Published:	Elsevier 2020-07-01
Series:	European Urology Open Science
Online Access:	http://www.sciencedirect.com/science/article/pii/S2666168320328330

id	doaj-e8d4b4389a2442c787708a47f86e1dcd
record_format	Article
spelling	doaj-e8d4b4389a2442c787708a47f86e1dcd2020-12-30T04:14:39ZengElsevierEuropean Urology Open Science2666-16832020-07-0119e409Do patients with advanced germ cell tumors still need Postchemotherapy Retroperitoneal Lymph Node Dissection (PC-RPLND) if the two best models predict a “benign” pathohistology?T. NestlerP. PaffenholzB. BaeßlerM. HellmichA. HiesterA. NiniD. PfisterP. AlbersA. Heidenreichhttp://www.sciencedirect.com/science/article/pii/S2666168320328330
collection	DOAJ
language	English
format	Article
sources	DOAJ
author	T. Nestler P. Paffenholz B. Baeßler M. Hellmich A. Hiester A. Nini D. Pfister P. Albers A. Heidenreich
spellingShingle	T. Nestler P. Paffenholz B. Baeßler M. Hellmich A. Hiester A. Nini D. Pfister P. Albers A. Heidenreich Do patients with advanced germ cell tumors still need Postchemotherapy Retroperitoneal Lymph Node Dissection (PC-RPLND) if the two best models predict a “benign” pathohistology? European Urology Open Science
author_facet	T. Nestler P. Paffenholz B. Baeßler M. Hellmich A. Hiester A. Nini D. Pfister P. Albers A. Heidenreich
author_sort	T. Nestler
title	Do patients with advanced germ cell tumors still need Postchemotherapy Retroperitoneal Lymph Node Dissection (PC-RPLND) if the two best models predict a “benign” pathohistology?
title_short	Do patients with advanced germ cell tumors still need Postchemotherapy Retroperitoneal Lymph Node Dissection (PC-RPLND) if the two best models predict a “benign” pathohistology?
title_full	Do patients with advanced germ cell tumors still need Postchemotherapy Retroperitoneal Lymph Node Dissection (PC-RPLND) if the two best models predict a “benign” pathohistology?
title_fullStr	Do patients with advanced germ cell tumors still need Postchemotherapy Retroperitoneal Lymph Node Dissection (PC-RPLND) if the two best models predict a “benign” pathohistology?
title_full_unstemmed	Do patients with advanced germ cell tumors still need Postchemotherapy Retroperitoneal Lymph Node Dissection (PC-RPLND) if the two best models predict a “benign” pathohistology?
title_sort	do patients with advanced germ cell tumors still need postchemotherapy retroperitoneal lymph node dissection (pc-rplnd) if the two best models predict a “benign” pathohistology?
publisher	Elsevier
series	European Urology Open Science
issn	2666-1683
publishDate	2020-07-01
url	http://www.sciencedirect.com/science/article/pii/S2666168320328330
work_keys_str_mv	AT tnestler dopatientswithadvancedgermcelltumorsstillneedpostchemotherapyretroperitoneallymphnodedissectionpcrplndifthetwobestmodelspredictabenignpathohistology AT ppaffenholz dopatientswithadvancedgermcelltumorsstillneedpostchemotherapyretroperitoneallymphnodedissectionpcrplndifthetwobestmodelspredictabenignpathohistology AT bbaeßler dopatientswithadvancedgermcelltumorsstillneedpostchemotherapyretroperitoneallymphnodedissectionpcrplndifthetwobestmodelspredictabenignpathohistology AT mhellmich dopatientswithadvancedgermcelltumorsstillneedpostchemotherapyretroperitoneallymphnodedissectionpcrplndifthetwobestmodelspredictabenignpathohistology AT ahiester dopatientswithadvancedgermcelltumorsstillneedpostchemotherapyretroperitoneallymphnodedissectionpcrplndifthetwobestmodelspredictabenignpathohistology AT anini dopatientswithadvancedgermcelltumorsstillneedpostchemotherapyretroperitoneallymphnodedissectionpcrplndifthetwobestmodelspredictabenignpathohistology AT dpfister dopatientswithadvancedgermcelltumorsstillneedpostchemotherapyretroperitoneallymphnodedissectionpcrplndifthetwobestmodelspredictabenignpathohistology AT palbers dopatientswithadvancedgermcelltumorsstillneedpostchemotherapyretroperitoneallymphnodedissectionpcrplndifthetwobestmodelspredictabenignpathohistology AT aheidenreich dopatientswithadvancedgermcelltumorsstillneedpostchemotherapyretroperitoneallymphnodedissectionpcrplndifthetwobestmodelspredictabenignpathohistology
_version_	1724367033371459584

Do patients with advanced germ cell tumors still need Postchemotherapy Retroperitoneal Lymph Node Dissection (PC-RPLND) if the two best models predict a “benign” pathohistology?

Similar Items